Aclaris Therapeutics Reports Second Quarter 2017 Financial Results
Aug 08, 2017 11:01 am UTC| Business
MALVERN, Pa., Aug. 08, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company, today announced financial results for the second quarter of 2017 and provided an update on its...
Kratos Receives $8 Million in Orders for Satellite Global Position Protection System
Aug 08, 2017 11:01 am UTC| Business
SAN DIEGO, Aug. 08, 2017 -- Kratos Defense Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that it has received $8 million in orders for specialized products in...
Agios Reports Second Quarter 2017 Financial Results
Aug 08, 2017 11:01 am UTC| Business
– IDHIFA® (enasidenib) Granted Approval from FDA as First Targeted Therapy for Patients with IDH2m R/R AML and First Product Approved from Agios’ Discovery Platform – – Trial Designs Finalized for Two Pivotal Studies for...
Akcea Reports Financial Results and Highlights for Second Quarter 2017
Aug 08, 2017 11:01 am UTC| Business
Marketing authorization application submitted to the European Medicines Agency for the approval of volanesorsen Cash balance of approximately $300 million to fund volanesorsen launch and cardiometabolic pipeline...
Lifetime Brands, Inc. Reports Second Quarter Financial Results
Aug 08, 2017 11:01 am UTC| Business
GARDEN CITY, N.Y., Aug. 08, 2017 -- Lifetime Brands, Inc. (NasdaqGS:LCUT), a leading global provider of branded kitchenware, tableware and other products used in the home, today reported its financial results for the...
Aug 08, 2017 11:01 am UTC| Business
SAN DIEGO and LONDON, Aug. 08, 2017 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced the addition of near-field communication...
Aclaris Therapeutics Acquires Confluence Life Sciences, Inc.
Aug 08, 2017 11:01 am UTC| Business
Expands pipeline of medicines for the potential treatment of patients with autoimmune disordersManagement to Host Conference Call at 8:30 AM ET today MALVERN, Pa., Aug. 08, 2017 -- Aclaris Therapeutics, Inc....